+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Global Ophthalmic Drugs Market to Reach US$21.6 bn by 2018 due to High Incidence of Eye-related Disorders amongst Geriatrics

Posted on Mar 25, 2016

Transparency Market Research has recently published a research report that details the trends and dynamics in the global ophthalmic drugs market. The research report, titled “Ophthalmic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018,” has been compiled using primary and secondary research methodologies. Furthermore, researchers have also used SWOT analysis to highlight the strengths, weaknesses, opportunities, and threats of the major companies and the overall market. The report includes a study of the historical data and its correlation with the current market scenario to shed light on the trajectory of the global ophthalmic drugs market.

Browse the full Ophthalmic Drugs Market (Dry eye, Anti-glaucoma, Anti-allergy/inflammatory/infective, Retinal Drugs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2018 report at http://www.transparencymarketresearch.com/ophthalmic-drugs-market.html

According to the research report, the global ophthalmic drugs market was valued at US$16 bn in 2012 and is estimated to reach a market value of US$21.6 bn by 2018, rising at a CAGR of 5.2% from 2013 to 2018. Ophthalmic drugs or ophthalmic medications refer to ointments, drops, or intraocular disks that are prescribed to patients with eye-related disorders. The remarkable growth of the global ophthalmic drugs market in the last few years is related to the high incidence of eye disorders due to the increasing number of diabetics, the growing pool of the aging population, and macular degeneration. The significant number of technological advancements in drug delivery techniques and increasing awareness about and prevalence of lifestyle-related diseases are also propelling the global ophthalmic drugs market.

The global ophthalmic drugs market is segmented on the basis of type, treatment drug, and geography. The types of drugs in this market are OTC drugs and prescription drugs. On the basis of treatment drug, this market is segmented into retinal drugs, dry eye drugs, anti-inflammatory or allergy or infective drugs, and anti-glaucoma drugs. Geographically, this market is segmented into Europe, North America, Asia Pacific, and Rest of the World. Amongst treatment drugs, the anti-glaucoma drugs segment is leading the global ophthalmic treatment drugs market, with a CAGR of 4.2% expected during the mentioned forecast period.

In terms of regions, North America dominates the overall ophthalmic drugs market and is likely to maintain its dominance due to the growing initiatives to prevent blindness and other disorders related to the eyes amongst the aging population. During the same forecast period of 2013-2018, the ophthalmic drugs market in Asia Pacific is also expected to witness strong growth due to the increasing ophthalmic disorders amongst geriatrics in the region. Countries such as China, India, and others in Southeast Asia are expected to be the largest consumers of these drugs, thereby propelling the ophthalmic drugs market in Asia Pacific.

Some of the key players in the global ophthalmic drugs market are Santen Pharmaceutical Co. Ltd., Merck & Co. Inc., Roche Holding AG, Pfizer Inc., Allergan Inc., and Novartis International AG. Presently, Novartis leads the global ophthalmic drugs market with a share of 24% in the overall market as of 2012. The research report provides a detailed analysis of the competitive landscape of the global ophthalmic drugs market and the regulatory framework influencing the overall market. Additionally, the report also explains the research and development activities, financial overview, investment outlook, and product portfolio of these top players.

The global ophthalmic drugs market is segmented into: 

By Types

  • Prescription Drugs
  • OTC Drugs

By Treatment Drugs

  • Dry Eye Drugs
  • Retinal Drugs
  • Anti-inflammatory/allergy/infective Drugs
  • Anti-glaucoma Drugs

By Regions

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW) 

Browse : Our new press releases http://www.transparencymarketresearch.com/pressrelease/ophthalmic-drugs-industry.htm

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.


Mr.Sudip S 
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Back To Top